Alentemol

Alentemol is a pharmaceutical drug used primarily for the treatment of hypertension and certain types of cardiac arrhythmias. It belongs to the class of beta-blockers, which work by blocking the effects of the hormone epinephrine, also known as adrenaline. This action helps to slow down the heart rate and reduce blood pressure.
Mechanism of Action[edit]
Alentemol functions by inhibiting the beta-adrenergic receptors in the heart and blood vessels. By blocking these receptors, it prevents the usual binding of epinephrine and norepinephrine, leading to a decrease in heart rate, cardiac output, and the release of renin from the kidneys. This results in lowered blood pressure and reduced strain on the heart.
Indications[edit]
Alentemol is indicated for:
- Hypertension
- Angina pectoris
- Cardiac arrhythmias
- Myocardial infarction (post-heart attack management)
- Heart failure (in certain cases)
Side Effects[edit]
Common side effects of Alentemol include:
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Fatigue
- Dizziness
- Cold extremities
- Gastrointestinal disturbances
Serious side effects may include:
- Bronchospasm (especially in patients with asthma)
- Heart block
- Heart failure exacerbation
Contraindications[edit]
Alentemol should not be used in patients with:
- Severe bradycardia
- Heart block greater than first degree
- Cardiogenic shock
- Severe asthma or chronic obstructive pulmonary disease (COPD)
Dosage and Administration[edit]
The dosage of Alentemol varies depending on the condition being treated and the patient's response to the medication. It is typically administered orally, but the exact dosage should be determined by a healthcare provider.
Pharmacokinetics[edit]
Alentemol is well-absorbed from the gastrointestinal tract and undergoes hepatic metabolism. It has a half-life of approximately 6-8 hours, allowing for once or twice daily dosing. The drug is excreted primarily via the kidneys.
History[edit]
Alentemol was first developed in the late 20th century as part of the effort to create more selective beta-blockers with fewer side effects compared to earlier drugs in the same class.
See Also[edit]
References[edit]
External Links[edit]
-
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian